Search results
New COVID-19 'FLiRT' Variants Are The Most Dominant In The U.S.
Women's Health via AOL· 4 days agoHow should I protect myself against the FLiRT variant of COVID-19? In good news, the CDC hasn't...
What Are The Symptoms Of The New COVID-19 Variants?
IFLScience· 4 days agoCOVID-19 is very much still with us – and if you’re anything like us, you’ll have noticed more and more people complaining that they’re getting sick over...
What should people know about the new coronavirus variant? A doctor explains.
CNN via Yahoo News· 2 days agoThe Covid-19 variant KP.2 has become the dominant strain in the US in recent weeks. We talked to our...
When Cells Turn Against Us: The Ferroptosis Link in COVID-19 Lung Destruction
SciTechDaily· 5 days agoResearchers at Columbia University have discovered that ferroptosis, a specific type of cell death,...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 3 days agoWhen COVID-19 vaccines entered the commercial market last fall, the federal government introduced a...
Mystery Finally Solved? New Discovery Could Explain Long COVID
SciTechDaily· 6 days agoResearchers at UVA Health have uncovered a potential explanation for some of the most puzzling...
CAR T-Cell therapy revolutionised landscape of cancer treatment: Doctors
Investing.com· 5 days agoNew Delhi, May 21 (IANS) A 42-year-old man from Bengaluru has successfully achieved "durable...
Boy battles Long COVID as family seeks alternative treatment
WBAL-TV Baltimore· 3 days agoAn Eastern Shore teenager is battling Long COVID as his family seeks alternative treatments. An...
‘No reason to panic’ in Singapore, even with latest wave of Covid-19 infections
South China Morning Post· 16 hours agoSince news about the rise in the number of cases broke, many pharmacies have seen Covid-19 test kits...
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
FOX 23 News Albany· 6 days agoThe primary results showed that treatment with Tezspire led to a 17% numerical reduction in the annual rate of moderate or severe COPD exacerbations compared ...